The role of celiac disease in severity of liver disorders and effect of a gluten free diet on diseases improvement

Hepatitis Monthly

Volumn 13, Issue 10, 2013, Pages

  Rostami Nejad, Mohammad ^a   Haldane, Thea ^b   Aldulaimi, David ^b   Alavian, Seyed Moayed ^c,d   Zali, Mohammad Reza ^a   Rostami, Kamran ^e  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NHS   (United Kingdom)

^c BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Middle East Liver Disease Center   (Iran)

^e DARENT VALLEY HOSPITAL   (United Kingdom)

Author keywords

Celiac disease; Liver disease; Severity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

AUTOIMMUNE HEPATITIS; AUTOIMMUNE LIVER DISEASE; BILIARY CIRRHOSIS; CELIAC DISEASE; DISEASE SEVERITY; GLUTEN FREE DIET; HEMOCHROMATOSIS; HEPATITIS C; HUMAN; HYPERTRANSAMINASEMIA; INTESTINE VILLUS ATROPHY; LIVER DISEASE; LIVER FIBROSIS; LIVER FUNCTION; LIVER TRANSPLANTATION; NONALCOHOLIC FATTY LIVER; PORTAL HYPERTENSION; REVIEW; SCLEROSING CHOLANGITIS; VIRUS HEPATITIS;

EID: 84887480161     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.11893     Document Type: Review

References (69)

1. Rubio-Tapia A, Murray JA. The liver in celiac disease. Hepatology. 2007;46(5):1650-8.
2. Zali MR, Rostami Nejad M, Rostami K, Alavian SM. Liver complications in celiac disease. Hepat Mon. 2011;11(5):333-41.
3. Hu WT, Murray JA, Greenaway MC, Parisi JE, Josephs KA. Cognitive impairment and celiac disease. Arch Neurol. 2006;63(10):1440-6.
4. Rostami Nejad M, Rostami K, Pourhoseingholi MA, Nazemalhosseini Mojarad E, Habibi M, Dabiri H, et al. Atypical presentation is dominant and typical for coeliac disease. J Gastrointestin Liver Dis. 2009;18(3):285-91.
5. Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology. 2006;131(6):1981-2002.
6. Bardella MT, Fraquelli M, Quatrini M, Molteni N, Bianchi P, Conte D. Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten-free diet. Hepatology. 1995;22(3):833-6.
7. Bonamico M, Pitzalis G, Culasso F, Vania A, Monti S, Benedetti C, et al. [Hepatic damage in celiac disease in children]. Minerva Pediatr. 1986;38(21):959-62.
8. Hagander B, Berg NO, Brandt L, Nordén A, SjöLund K, Stenstam M. Hepatic injury in adult celiac disease. The Lancet. 1977;310(8032):270-272.
9. Bardella MT, Vecchi M, Conte D, Del Ninno E, Fraquelli M, Pacchetti S, et al. Chronic unexplained hypertransaminasemia may be caused by occult celiac disease. Hepatology. 1999;29(3):654-7.
10. Volta U, Franceschi LD, Lari F, Molinaro N, Zoli M, Bianchi FB. Coeliac disease hidden by cryptogenic hypertransaminasaemia. The Lancet. 1998;352(9121):26-29.
11. Lindgren S, Sjoberg K, Eriksson S. Unsuspected Coeliac Disease in Chronic 'Cryptogenic' Liver Disease. Scand J Gastroentero. 1994;29(7):661-664.
12. Ludvigsson JF, Elfstrom P, Broome U, Ekbom A, Montgomery SM. Celiac disease and risk of liver disease: a general population-based study. Clin Gastroenterol Hepatol. 2007;5(1):63-9 e1.
13. Peters U, Askling J, Gridley G, Ekbom A, Linet M. Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med. 2003;163(13):1566-72.
14. Green RM, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology. 2002;123(4):1367-84.
15. Rubio-Tapia A, Abdulkarim AS, Wiesner RH, Moore SB, Krause PK, Murray JA. Celiac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantation. Liver Int. 2008;28(4):467-76.
16. Villalta D, Girolami D, Bidoli E, Bizzaro N, Tampoia M, Liguori M, et al. High prevalence of celiac disease in autoimmune hepatitis detected by anti-tissue tranglutaminase autoantibodies. J Clin Lab Anal. 2005;19(1):6-10.
17. Volta U, De Franceschi L, Molinaro N, Cassani F, Muratori L, Lenzi M, et al. Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci. 1998;43(10):2190-5.
18. Bardella MT, Quatrini M, Zuin M, Podda M, Cesarini L, Velio P, et al. Screening patients with celiac disease for primary biliary cirrhosis and vice versa. Am J Gastroenterol. 1997;92(9):1524-6.
19. Dickey W, McMillan SA, Callender ME. High prevalence of celiac sprue among patients with primary biliary cirrhosis. J Clin Gastroenterol. 1997;25(1):328-9.
20. Floreani A, Betterle C, Baragiotta A, Martini S, Venturi C, Basso D, et al. Prevalence of coeliac disease in primary biliary cirrhosis and of antimitochondrial antibodies in adult coeliac disease patients in Italy. Dig Liver Dis. 2002;34(4):258-61.
21. Kingham J G C, Parker D R. The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences. Gut. 1998;42(1):120-122.
22. Volta U, Rodrigo L, Granito A, Petrolini N, Muratori P, Muratori L, et al. Celiac disease in autoimmune cholestatic liver disorders. Am J Gastroenterol. 2002;97(10):2609-13.
23. Di Tola M, Sabbatella L, Anania MC, Viscido A, Caprilli R, Pica R, et al. Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidence. Clin Chem Lab Med. 2004;42(10):1092-7.
24. Eapen CE, Nightingale P, Hubscher SG, Lane PJ, Plant T, Velissaris D, et al. Non-cirrhotic intrahepatic portal hypertension: associated gut diseases and prognostic factors. Dig Dis Sci. 2011;56(1):227-35.
25. Fine KD, Ogunji F, Saloum Y, Beharry S, Crippin J, Weinstein J. Celiac sprue: another autoimmune syndrome associated with hepatitis C. Am J Gastroenterol. 2001;96(1):138-45.
26. Durante-Mangoni E, Iardino P, Resse M, Cesaro G, Sica A, Farzati B, et al. Silent celiac disease in chronic hepatitis C: impact of interferon treatment on the disease onset and clinical outcome. J Clin Gastroenterol. 2004;38(10):901-5.
27. Rostami Nejad M, Mohebbi SR, Rostami K, Cheraghipour K, Zali MR. Is there any association between chronic Hepatitis C virus and celiac disease? International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2010;14.
28. Sima H, Hekmatdoost A, Ghaziani T, Alavian SM, Mashayekh A, Zali MR. The prevalence of celiac autoantibodies in hepatitis patients. Iran J Allergy Asthma Immunol. 2010;9(3):157-62.
29. Leonardi S, La Rosa M. Are hepatitis B virus and celiac disease linked? Hepat Mon. 2010;10(3):173-5.
30. Bardella MT, Valenti L, Pagliari C, Peracchi M, Fare M, Fracanzani AL, et al. Searching for coeliac disease in patients with non-alcoholic fatty liver disease. Dig Liver Dis. 2004;36(5):333-6.
31. Lo Iacono O, Petta S, Venezia G, Di Marco V, Tarantino G, Barbaria F, et al. Anti-tissue transglutaminase antibodies in patients with abnormal liver tests: is it always coeliac disease? Am J Gastroenterol. 2005;100(11):2472-7.
32. Barisani D, Ceroni S, Del Bianco S, Meneveri R, Bardella MT. Hemochromatosis gene mutations and iron metabolism in celiac disease. Haematologica. 2004;89(11):1299-305.
33. Butterworth JR, Cooper BT, Rosenberg WM, Purkiss M, Jobson S, Hathaway M, et al. The role of hemochromatosis susceptibility gene mutations in protecting against iron deficiency in celiac disease. Gastroenterology. 2002;123(2):444-9.
34. Heneghan MA, Feeley KM, Stevens FM, Little MP, McCarthy CF. Precipitation of iron overload and hereditary hemochromatosis after successful treatment of celiac disease. Am J Gastroenterol. 2000;95(1):298-300.
35. Turcu A, Leveque L, Bielefeld P, Besancenot JF, Hillon P. Adult celiac disease and hemochromatosis. Am J Gastroenterol. 2000;95(12):3661-2.
36. Novacek G, Miehsler W, Wrba F, Ferenci P, Penner E, Vogelsang H. Prevalence and clinical importance of hypertransaminasaemia in coeliac disease. Eur J Gastroenterol Hepatol. 1999;11(3):283-8.
37. Maggiore G, Caprai S. The Liver in Celiac Disease. J Paediatr gastroenterol nutri. 2003;37(2):117-119.
38. Klein J, Sato A. The HLA system. First of two parts. N Engl J Med. 2000;343(10):702-9.
39. Murray JA, Watson T, Clearman B, Mitros F. Effect of a gluten-free diet on gastrointestinal symptoms in celiac disease. Am J Clin Nutr. 2004;79(4):669-73.
40. West J, Logan RF, Smith CJ, Hubbard RB, Card TR. Malignancy and mortality in people with coeliac disease: population based cohort study. BMJ. 2004;329(7468):716-9.
41. Logan RFA, Ferguson A, Finlayson NDC, Weir DG. PRIMARY BILIARY CIRRHOSIS AND COELIAC DISEASE: An Association? The Lancet. 1978;311(8058):230-233.
42. Gillett HR, Cauch-Dudek K, Jenny E, Heathcote EJ, Freeman HJ. Prevalence of IgA antibodies to endomysium and tissue transglutaminase in primary biliary cirrhosis. Can J Gastroenterol. 2000;14(8):672-5.
43. Gogos CA, Nikolopoulou V, Zolota V, Siampi V, Vagenakis A. Autoimmune cholangitis in a patient with celiac disease: a case report and review of the literature. J Hepatol. 1999;30(2):321-4.
44. Lawson A, West J, Aithal GP, Logan RF. Autoimmune cholestatic liver disease in people with coeliac disease: a population-based study of their association. Aliment Pharmacol Ther. 2005;21(4):401-5.
45. Feld JJ, Meddings J, Heathcote EJ. Abnormal intestinal permeability in primary biliary cirrhosis. Dig Dis Sci. 2006;51(9):1607-13.
46. Schwabe RF, Seki E, Brenner DA. Toll-like receptor signaling in the liver. Gastroenterology. 2006;130(6):1886-900.
47. Watt FE, James OF, Jones DE. Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study. QJM. 2004;97(7):397-406.
48. Ouakaa-Kchaou A, Gargouri D, Kharrat J, Ghorbel A. Relationship between Hepatitis B Virus Infection and Celiac Disease. Hepat Mon. 2010;10(4):313-4.
49. Plot L, Amital H. Infectious associations of Celiac disease. Autoimmun Rev. 2009;8(4):316-9.
50. Zamani F, Amiri A, Shakeri R, Zare A, Mohamadnejad M. Celiac disease as a potential cause of idiopathic portal hypertension: a case report. J Med Case Rep. 2009;3:68.
51. Adinolfi LE, Durante Mangoni E, Andreana A. Interferon and ribavirin treatment for chronic hepatitis C may activate celiac disease. Am J Gastroenterol. 2001;96(2):607-8.
52. Bardella MT, Marino R, Meroni PL. Celiac disease during interferon treatment. Ann Intern Med. 1999;131(2):157-8.
53. Cammarota G, Cuoco L, Cianci R, Pandolfi F, Gasbarrini G. Onset of coeliac disease during treatment with interferon for chronic hepatitis C. The Lancet. 2000;356(9240):1494-1495.
54. Monteleone G, Pender SL, Wathen NC, MacDonald TT. Interferon-alpha drives T cell-mediated immunopathology in the intestine. Eur J Immunol. 2001;31(8):2247-55.
55. Narvaez I, Perez B, del Mar Alcalde M, Jimenez C, Soria A. Chronic viral hepatitis, interferon, diabetes mellitus, and celiac disease. Am J Gastroenterol. 2003;98(10):2336-7.
56. Tam RC, Pai B, Bard J, Lim C, Averett DR, Phan UT, et al. Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile. J Hepatol. 1999;30(3):376-82.
57. Burgos A, Bermejo PE. The Controversial Link between Hepatitis B Virus and Celiac Disease. Hepat Mon. 2010;10(4):310.
58. Collin P. Celiac disease and liver. Hepat Mon. 2010;10(4):315-6.
59. Freeman HJ. Hepatitis B and celiac disease. Hepat Mon. 2010;10(4):317.
60. Rostami Nejad M, Rostami K, Zali MR. Hepatitis B vaccination reliability in celiac disease. Hepat Mon. 2011;11(8):597-8.
61. Tursi A. Celiac disease and viral B hepatitis: lessons for clinical practice. Hepat Mon. 2010;10(4):311-2.
62. Noh KW, Poland GA, Murray JA. Hepatitis B vaccine nonresponse and celiac disease. Am J Gastroenterol. 2003;98(10):2289-92.
63. Park SD, Markowitz J, Pettei M, Weinstein T, Sison CP, Swiss SR, et al. Failure to respond to hepatitis B vaccine in children with celiac disease. J Pediatr Gastroenterol Nutr. 2007;44(4):431-5.
64. Rostami K, Rostami Nejad M. Vaccinations in celiac disease. J Pediatr Gastroenterol Nutr. 2013;56(4):341-2.
65. Alavian SM, Mohammad-Alizadeh AH, Esna-Ashari F, Ardalan G, Hajarizadeh B. Non-alcoholic fatty liver disease prevalence among school-aged children and adolescents in Iran and its association with biochemical and anthropometric measures. Liver Int. 2009;29(2):159-63.
66. Angulo P, Lindor KD. Non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2002;17 Suppl:S186-90.
67. Miele L, Valenza V, La Torre G, Montalto M, Cammarota G, Ricci R, et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology. 2009;49(6):1877-87.
68. Kaukinen K, Halme L, Collin P, Farkkila M, Maki M, Vehmanen P, et al. Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure. Gastroenterology. 2002;122(4):881-8.
69. Elli L, Bergamini CM, Bardella MT, Schuppan D. Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver. Dig Liver Dis. 2009;41(8):541-50.